CT-guided 125I brachytherapy for hepatocellular carcinoma in high-risk locations after transarterial chemoembolization combined with microwave ablation: a propensity score-matched study
This study aimed to evaluate the safety and efficacy of 125I brachytherapy combined with transarterial chemoembolization (TACE) and microwave ablation (MWA) for unresectable hepatocellular carcinoma (HCC) in high-risk locations.
Zapisane w:
| Główni autorzy: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Sciendo
2023-03-01
|
| Seria: | Radiology and Oncology |
| Hasła przedmiotowe: | |
| Dostęp online: | https://doi.org/10.2478/raon-2023-0012 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|
